Inside Indiana Business reports on healthcare software startup Digital Health Solutions

headshot of Dr. Stephen Downs
Dr. Stephen Downs, President, Digital Health Solutions LLC

Digital Health Solutions is a software startup founded by Dr. Stephen Downs and Tammy Dugan, two members of the Indiana University School of Medicine.

The company’s first product, software called CHICA, or Child Health Improvement through Computer Automation, has been used at Eskenazi Hospital for several years. The company licenses the technology through Indiana University Research and Technology Corp. and is a member of the Spin Up entrepreneurial program.

Inside Indiana Business reports on the company in an article that you can read here. There are two audio files attached to the article.

headshot of Tammy Dugan
Tammy Dugan, Chief Technology Officer, Digital Health Solutions

A news release about the company is available here.

Congratulations to Dr. Downs and Dugan on launching Digital Health Solutions!

Watch Jennifer Finefield of IURTC on Inside Indiana Business with Gerry Dick!

headshot of Jennifer Finefield
Jennifer Finefield, Senior Technology Manager, Indiana University Research and Technology Corporation

Jennifer Finefield, senior technology manager at Indiana University Research and Technology Corp., appeared on Inside Indiana Business with Gerry Dick to speak about a record year in prototype development for a collaboration between IURTC and Rose-Hulman Ventures.

You can watch the five-minute interview here.

A news release about the collaboration is available here.

Well done, Jennifer!

Jennifer Finefield of IURTC to appear on Inside Indiana Business TV!

Jennifer Finefield (IURTC) and Elizabeth Hagerman (Rose-Hulman Ventures) sit on one side of a curved desk branded "Inside Indiana Business" across from Gerry Dick, the show's host.
Jennifer Finefield (L) of IURTC and Elizabeth Hagerman of Rose-Hulman Ventures speak with Gerry Dick of “Inside Indiana Business with Gerry Dick” about the collaboration between the organizations.

Jennifer Finefield, senior technology manager at Indiana University Research and Technology Corp., will appear on “Inside Indiana Business with Gerry Dick” alongside Elizabeth Hagerman of Rose-Hulman Ventures.

They will speak with Gerry Dick about the collaboration between the two organizations, which culminated in a record eight prototypes being developed in the 2016 calendar year.

WFYI, the PBS station in Indianapolis, will broadcast the interview Friday, February 24 at 7:30 p.m. WTIU, the PBS station in Bloomington, will broadcast it Saturday, February 25 at 4:30 p.m. The complete listing of “Inside Indiana Business with Gerry Dick” broadcast days and times is available here.

A news release about the record year for the IURTC/Rose-Hulman Ventures collaboration is available here.

Well done, Jennifer!

Drone tech company that received Innovate Indiana Fund investment announces partnership

PrecisionHawk, which received an investment from the Innovate Indiana Fund, has more great news!

The company has selected Sierra Wireless AirPrime® MC Series embedded modules to enable global LTE connectivity for its Low Altitude Traffic and Airspace Safety (LATAS) platform, which enables safe drone operation on a broad scale.

Congratulations to PrecisionHawk! You can read a news release here.

CEO of company that licenses IU cancer pharmaceutical research scheduled to speak in Philadelphia

Steve Carchedi, President and CEO of Apexian Pharmaceuticals, is scheduled to speak March 1 at Drexel University’s Healthcare Guest Lecture Series in Philadelphia.

headshot of Steve Carchedi
Steve Carchedi, President and CEO, Apexian Pharmaceuticals

“Drexel has a wonderful history of developing leaders in the healthcare industry,” Carchedi said. “We are honored to partner with faculty at Drexel to attract talent to pursue development of life-saving medicines, like our lead molecule, APX3330, that is ready to advance into the clinic. Hopefully, some of these students will be leading the effort for future breakthrough medicines.”

Apexian Pharmaceuticals, formerly ApeX Therapeutics, recently announced acceptance by the U.S. Food and Drug Administration of an Investigational New Drug Application to evaluate the tolerability and anti-tumor effects of APX3330, a small molecule in development to treat late stage cancer. The company licenses IU-discovered research through Indiana University Research and Technology Corp.

A news release about Carchedi and Drexel University’s Healthcare Guest Lecture Series is available here.

From BioCrossroads: $63B economic impact of statewide life sciences sector

BioCrossroads, the state of Indiana’s initiative to grow the life sciences, reports that the life sciences sector had a $63 billion economic impact on the state according to the most recent data available.

“For the biotech sector, national and even global forces drive constant change for business models, product approvals and investments, and ultimately, innovation, but Indiana’s life sciences industry maintained its strong leadership position over the past year with an outsized number of employees, companies and exports,” said David L. Johnson, president and CEO of BioCrossroads.

BioCrossroads Infographic 1 Impact
Courtesy BioCrossroads

The complete news report is available here.

Hepatitis B drug developed by Assembly Biosciences advances through early safety, tolerability, pharmacokinetic evaluation

Assembly Biosciences Inc., a Carmel-based biotech company with numerous ties to Indiana University and the Hoosier State — has successfully completed part of a Phase I study for a lead drug being developed to treat chronic cases of hepatitis B.

The opening half of the study evaluated the safety, tolerability and pharmacokinetics (studies of how organisms affect a drug) of a compound known as ABI-H0731 in healthy volunteers. The second half of the study will assess safety, pharmacokinetics and preliminary antiviral efficacy of the drug in patients with chronic hepatitis B. The results of the first half of the study will be reported at a scientific conference later this year.

Founded in 2012, Assembly — which employs about 100 workers and consultants — is built in part around the research of Adam Zlotnick, a professor of molecular and cellular biochemistry at Indiana University Bloomington and co-founder of Assembly. By exploiting vulnerabilities in the capsid assembly of the hepatitis B virus (HBV), it is hoped that the chronic liver infection that it causes — which kills about 786,000 people annually and affects about 240 million people globally according to the Centers for Disease Control and Prevention — can be eradicated.

Other Assembly officials with IU or Indiana ties include:

  • William W. Turner, who co-founded Assembly with Zlotnick and is a former visiting scholar in biochemistry at IU-Bloomington. Turner is head of discovery chemistry at Assembly and served for 35 years as a research chemist at Indianapolis-based Eli Lilly & Co.
  • Derek Small, a co-founder, CEO and director of Assembly, who earned a bachelors degree in business from Franklin College.
  • Richard DiMarchi, an Assembly director who is the Cox Distinguished Professor of Biochemistry and Gill Chair in Biomolecular Sciences at IU-Bloomington.
  • Micah Mackison, Assembly’s vice president of corporate development and strategy, who earned his bachelors degree in finance from IU.
  • William Ringo, an Assembly director who also serves as a director for BioCrossroads, an Indiana initiative and public-private collaboration that focuses on growing, advancing and investing in the life sciences.

For more information, including details on upcoming Assembly conference presentations, click here.

Several companies with IU ties among nominees for 18th annual Mira Awards

Nominees for TechPoint’s 18th annual Mira Awards were recently revealed, with half of the 180 applications received advancing in this year’s competition.

The Miras honor the “Best of Tech” throughout Indiana and many of the nominees — as one might well imagine — have Indiana University ties.

One such company, nominated for Innovation of the Year, was Arrythmotech, whose co-founders are Dr. Peng-Sheng Chen and Shein-Fong Lin of the IU School of Medicine. Launched with the help of the Indiana University Research and Technology Corp.’s Spin Up program, the company is developing a device capable of detecting, on the skin, the nerve activity that is responsible for the body’s fight-or-flight response. Its platform technology could potentially be widely used in the medical field.

Also nominated for Innovation of the Year was IndyVitals by The Polis Center at Indiana University-Purdue University Indianapolis. A new digital monitoring tool for Marion County, IndyVitals is powered by SAVI, an interactive database created and managed by The Polis Center within IU’s School of Liberal Arts in partnership with The United Way of Central Indiana.

Nominated as Tech Educator of the Year was the Informatics Diversity-Enhanced Workforce (iDEW) at IU’s School of Informatics and Computing at IUPUI. IDEW is a workforce development initiative with the IU School of Informatics and Computing at IUPUI in collaboration with communities throughout Indiana — plus IU business partners and high schools.

A full list of Mira nominees is available here. Winners of the Mira Awards will be announced at a black-tie ceremony set for Saturday, April 29, at The Westin Indianapolis.